EP1937242A4 - Procedes et compositions pour traiter des troubles neuropsychiatriques et des troubles lies a la dependance - Google Patents
Procedes et compositions pour traiter des troubles neuropsychiatriques et des troubles lies a la dependanceInfo
- Publication number
- EP1937242A4 EP1937242A4 EP06826134A EP06826134A EP1937242A4 EP 1937242 A4 EP1937242 A4 EP 1937242A4 EP 06826134 A EP06826134 A EP 06826134A EP 06826134 A EP06826134 A EP 06826134A EP 1937242 A4 EP1937242 A4 EP 1937242A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- neuropsychiatric
- compositions
- treatment
- methods
- addictive disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72731805P | 2005-10-17 | 2005-10-17 | |
US72756405P | 2005-10-17 | 2005-10-17 | |
US11/251,724 US8008283B2 (en) | 1998-12-23 | 2005-10-17 | Methods and compositions for the treatment of neuropsychiatric disorders |
US11/549,274 US20070149526A1 (en) | 2005-10-17 | 2006-10-13 | Diuretic and diuretic-like compound analogs |
PCT/US2006/040598 WO2007047698A2 (fr) | 2005-10-17 | 2006-10-17 | Procedes et compositions pour traiter des troubles neuropsychiatriques et des troubles lies a la dependance |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1937242A2 EP1937242A2 (fr) | 2008-07-02 |
EP1937242A4 true EP1937242A4 (fr) | 2011-06-15 |
Family
ID=37963225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06826134A Withdrawn EP1937242A4 (fr) | 2005-10-17 | 2006-10-17 | Procedes et compositions pour traiter des troubles neuropsychiatriques et des troubles lies a la dependance |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1937242A4 (fr) |
WO (1) | WO2007047698A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017042314A1 (fr) * | 2015-09-11 | 2017-03-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Méthodes et composition pharmaceutique pour le traitement d'épilepsies post-traumatiques |
US11666547B2 (en) * | 2019-06-28 | 2023-06-06 | Northwestern University | Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020082252A1 (en) * | 1998-12-23 | 2002-06-27 | Cytoscan Sciences L.L.C. | Methods and compositions for treating conditions of the central and peripheral nervous systems using non-synaptic mechanisms |
WO2007047447A2 (fr) * | 2005-10-17 | 2007-04-26 | Neurotherapeutics Pharma, Inc. | Analogues de compose diuretique ou de type diuretique |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128327A (en) * | 1991-03-25 | 1992-07-07 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle |
US5162325A (en) * | 1991-05-07 | 1992-11-10 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted benzyl element |
-
2006
- 2006-10-17 WO PCT/US2006/040598 patent/WO2007047698A2/fr active Application Filing
- 2006-10-17 EP EP06826134A patent/EP1937242A4/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020082252A1 (en) * | 1998-12-23 | 2002-06-27 | Cytoscan Sciences L.L.C. | Methods and compositions for treating conditions of the central and peripheral nervous systems using non-synaptic mechanisms |
WO2007047447A2 (fr) * | 2005-10-17 | 2007-04-26 | Neurotherapeutics Pharma, Inc. | Analogues de compose diuretique ou de type diuretique |
Non-Patent Citations (1)
Title |
---|
M. A. COLLINS ET AL.: "Brain damage due to episodic alcohol exposure in vivo and in vitro: furosemide neuroprotection implicates edema-based mechanism", THE FASEB JOURNAL, vol. 12, 1998, pages 221 - 230, XP002634773 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007047698A3 (fr) | 2007-07-05 |
EP1937242A2 (fr) | 2008-07-02 |
WO2007047698A2 (fr) | 2007-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200607433B (en) | Methods and compositions for the treatment of gastroin-testinal disorders | |
EP1874286A4 (fr) | Methodes et compositions pour le traitement de troubles anxieux | |
EP1853295A4 (fr) | Procedes et compositions pour le traitement de troubles gastro-intestinaux | |
EP1940441A4 (fr) | Compositions et methodes de traitement de troubles gastro-intestinaux | |
IL177772A0 (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
EP1893216A4 (fr) | Methodes et preparations pour le traitement de troubles oculaires | |
EP1871909A4 (fr) | Compositions et procédés pour le diagnostic et le traitement de troubles neuropsychiatriques | |
IL208607A0 (en) | Improved nanobodiestm for the treatment of aggregation-mediated disorders | |
IL190913B (en) | Preparations for the treatment of sweating disorders | |
IL180187A0 (en) | Compositions and methods for treating inflammatory disorders | |
IL191283A (en) | Compositions for treating eye irregularities | |
IL179508A0 (en) | 2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders | |
IL179766A0 (en) | Compositions and methods using same for treating neurodegenerative disorders | |
IL181896A0 (en) | Methods and compositions for the treatment of hyperlipidemia | |
EP1901733A4 (fr) | Utilisation d'huperzine pour des pathologies | |
EP1644021A4 (fr) | Methodes et compositions pour le traitement de troubles gastro-intestinaux | |
EP1948675A4 (fr) | Methodes et compositions de traitement du syndrome de marfan et de troubles associes | |
ME01219B (me) | Alfa-aminoamid derivati korisni u liječenju bolesti zavisnosti | |
ZA200610661B (en) | Compositions and methods for treating neurological disorders | |
ZA200804500B (en) | Methods and compositions for the treatment of gastro-intestinal disorders | |
EP1996218A4 (fr) | Méthodes et compositions servant au traitement de troubles gastro-intestinaux | |
ZA200703087B (en) | Methods and compositions for the treatment of hyperlipidemia | |
ZA200804951B (en) | Compositions and methods for treating CNS disorders | |
IL189009A0 (en) | Methods and compositions for the treatment of neuropathies and related disorders | |
HK1121378A1 (en) | Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080331 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0031195000 Ipc: C07D0307520000 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/08 20060101ALI20110502BHEP Ipc: A61K 31/41 20060101ALI20110502BHEP Ipc: A61K 31/381 20060101ALI20110502BHEP Ipc: A61K 31/341 20060101ALI20110502BHEP Ipc: C07D 207/06 20060101ALI20110502BHEP Ipc: C07C 311/00 20060101ALI20110502BHEP Ipc: C07D 213/34 20060101ALI20110502BHEP Ipc: C07D 257/04 20060101ALI20110502BHEP Ipc: C07D 333/10 20060101ALI20110502BHEP Ipc: C07D 307/52 20060101AFI20110502BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20110513 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20111213 |